Literature DB >> 7688393

Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration.

I Iwamoto1, S Tomoe, H Tomioka, S Yoshida.   

Abstract

Substance P, a potent proinflammatory peptide present in sensory neurons, causes granulocyte (neutrophil and eosinophil) infiltration into mouse skin by inducing mast cell degranulation. However, the mediator responsible for this granulocyte infiltration has not been determined. In this study, we determined which mediator from cutaneous mast cells mediates substance P-induced granulocyte infiltration in the skin by the use of two mediator antagonists; one for platelet activating factor (PAF) CV-6209 and the other for leukotriene B4 (LTB4) ONO-4057. Subcutaneous injection of substance P (10(-7)-10(-5) M) caused granulocyte infiltration in the skin of BALB/c mice in a time- and concentration-dependent fashion. Pretreatment with the LTB4 antagonist decreased substance P-induced neutrophil and eosinophil infiltration into mouse skin at 6 h to the same extent that an inhibitor of mast cell degranulation, disodium cromoglycate, decreased those responses. However, pretreatment with the PAF antagonist affected neither substance P-induced neutrophil nor eosinophil infiltration at 6 h. A LTC4/D4 antagonist ONO-1078 and a histamine H1 antagonist chlorpheniramine had no effect on the granulocyte infiltration, either. The LTB4 antagonist also decreased substance P-induced neutrophil, but not eosinophil, infiltration into mouse skin at 24 h. In contrast, the PAF antagonist inhibited Ag-induced eosinophil infiltration of mouse skin, whereas the LTB4 antagonist inhibited the Ag-induced neutrophil infiltration. We conclude that LTB4 is a major mast cell-derived chemotactic mediator for initiating substance P-induced neutrophil and eosinophil infiltration into mouse skin. Our results suggest that LTB4 antagonists might be useful in preventing such neurogenic inflammation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688393

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  The release of leukotriene B4 from human skin in response to substance P: evidence for the functional heterogeneity of human skin mast cells among individuals.

Authors:  T Okabe; M Hide; O Koro; N Nimi; S Yamamoto
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Deficient eosinophil chemotaxis-promoting activity of genetically normal mast cells transplanted into subcutaneous tissue of Mitfmi-vga9/Mitfmi-vga9 mice: comparison of the activity and mast cell distribution pattern with KitW/KitW-vMice.

Authors:  Keisuke Oboki; Eiichi Morii; Yukihiko Kitamura
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

3.  Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro.

Authors:  H J Showell; R Breslow; M J Conklyn; G P Hingorani; K Koch
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  Cyclo-oxygenase and lipoxygenase pathways in mast cell dependent-neurogenic inflammation induced by electrical stimulation of the rat saphenous nerve.

Authors:  G Le Filliatre; S Sayah; V Latournerie; J F Renaud; M Finet; R Hanf
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

5.  Bitter taste signaling in tracheal epithelial brush cells elicits innate immune responses to bacterial infection.

Authors:  Monika I Hollenhorst; Rajender Nandigama; Saskia B Evers; Igor Gamayun; Noran Abdel Wadood; Alaa Salah; Mario Pieper; Amanda Wyatt; Alexey Stukalov; Anna Gebhardt; Wiebke Nadolni; Wera Burow; Christian Herr; Christoph Beisswenger; Soumya Kusumakshi; Fabien Ectors; Tatjana I Kichko; Lisa Hübner; Peter Reeh; Antje Munder; Sandra-Maria Wienhold; Martin Witzenrath; Robert Bals; Veit Flockerzi; Thomas Gudermann; Markus Bischoff; Peter Lipp; Susanna Zierler; Vladimir Chubanov; Andreas Pichlmair; Peter König; Ulrich Boehm; Gabriela Krasteva-Christ
Journal:  J Clin Invest       Date:  2022-07-01       Impact factor: 19.456

6.  Substance P-induced inflammatory responses in guinea-pig skin: the effect of specific NK1 receptor antagonists and the role of endogenous mediators.

Authors:  D T Walsh; V B Weg; T J Williams; S Nourshargh
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

7.  Mechanisms underlying the inhibitory effects of tachykinin receptor antagonists on eosinophil recruitment in an allergic pleurisy model in mice.

Authors:  Ana Leticia Alessandri; Vanessa Pinho; Danielle G Souza; Maria Salete de A Castro; Andre Klein; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2003-11       Impact factor: 8.739

8.  Dermal inflammation in primates, mice, and guinea pigs: attenuation by second-generation leukotriene B4 receptor antagonist, SC-53228.

Authors:  D J Fretland; R Gokhale; L Mathur; D A Baron; S K Paulson; J Stolzenbach
Journal:  Inflammation       Date:  1995-06       Impact factor: 4.092

9.  The association between alpha4-integrin, P-selectin, and E-selectin in an allergic model of inflammation.

Authors:  S Kanwar; D C Bullard; M J Hickey; C W Smith; A L Beaudet; B A Wolitzky; P Kubes
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.